Juvenile Diabetes Foundation Intl
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Juvenile Diabetes Foundation Intl
Names of Lobbyists
Firm Hired Amount Juvenile Diabetes Foundation Intl $250,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Fed Budget & Appropriations
Most Frequently Disclosed Bills
Bill No. Title H.R.1862 Regenerative Medicine Promotion Act of 2011 H.R.2112 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 H.R.2376 Stem Cell Research Advancement Act of 2011 H.R.2969 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 H.R.3988 Generic Drug and Biosimilar User Fee Act of 2012 H.R.4087 Prescription Drug Labeling Promotion Act of 2012 H.R.5334 To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies. S.1454 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011 S.1599 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.